HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3,5-Diiodothyronine in vivo maintains euthyroidal expression of type 2 iodothyronine deiodinase, growth hormone, and thyroid hormone receptor beta1 in the killifish.

Abstract
Until recently, 3,5-diiodothyronine (3,5-T(2)) has been considered an inactive by-product of triiodothyronine (T(3)) deiodination. However, studies from several laboratories have shown that 3,5-T(2) has specific, nongenomic effects on mitochondrial oxidative capacity and respiration rate that are distinct from those due to T(3). Nevertheless, little is known about the putative genomic effects of 3,5-T(2). We have previously shown that hyperthyroidism induced by supraphysiological doses of 3,5-T(2) inhibits hepatic iodothyronine deiodinase type 2 (D2) activity and lowers mRNA levels in the killifish in the same manner as T(3) and T(4), suggesting a pretranslational effect of 3,5-T(2) (Garcia-G C, Jeziorski MC, Valverde-R C, Orozco A. Gen Comp Endocrinol 135: 201-209, 2004). The question remains as to whether 3,5-T(2) would have effects under conditions similar to those that are physiological for T(3). To this end, intact killifish were rendered hypothyroid by administering methimazole. Groups of hypothyroid animals simultaneously received 30 nM of either T(3), reverse T(3), or 3,5-T(2). Under these conditions, we expected that, if it were bioactive, 3,5-T(2) would mimic T(3) and thus reverse the compensatory upregulation of D2 and tyroid receptor beta1 and downregulation of growth hormone that characterize hypothyroidism. Our results demonstrate that 3,5-T(2) is indeed bioactive, reversing both hepatic D2 and growth hormone responses during a hypothyroidal state. Furthermore, we observed that 3,5-T(2) and T(3) recruit two distinct populations of transcription factors to typical palindromic and DR4 thyroid hormone response elements. Taken together, these results add further evidence to support the notion that 3,5-T(2) is a bioactive iodothyronine.
AuthorsC García-G, L López-Bojorquez, J Nuñez, C Valverde-R, A Orozco
JournalAmerican journal of physiology. Regulatory, integrative and comparative physiology (Am J Physiol Regul Integr Comp Physiol) Vol. 293 Issue 2 Pg. R877-83 (Aug 2007) ISSN: 0363-6119 [Print] United States
PMID17522123 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Diiodothyronines
  • RNA, Messenger
  • Thyroid Hormone Receptors beta
  • 3,5-diiodothyronine
  • Growth Hormone
  • iodothyronine deiodinase type II
  • Iodide Peroxidase
Topics
  • Animals
  • Diiodothyronines (blood, pharmacology)
  • Fundulidae (physiology)
  • Gene Expression Regulation, Enzymologic (physiology)
  • Growth Hormone (blood)
  • Hyperthyroidism (metabolism, physiopathology)
  • Hypothyroidism (metabolism, physiopathology)
  • Iodide Peroxidase (genetics, metabolism)
  • Liver (drug effects, metabolism)
  • Male
  • RNA, Messenger (metabolism)
  • Response Elements (physiology)
  • Thyroid Gland (drug effects, physiology)
  • Thyroid Hormone Receptors beta (metabolism)
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: